Q3 2026 PI Industries Ltd Earnings Call Transcript
Key Points
- PI Industries Ltd (BOM:523642) reported a 50% year-on-year growth in its Pharma platform, driven by deepening relationships with biotech and big pharma innovators.
- The company has commercialized five new molecules in AgChem Exports and four in domestic Agri-brands, demonstrating a strong focus on innovation.
- PI Industries Ltd (BOM:523642) has launched a direct-to-farmer mobile app, PI Mitra Kisan, enhancing farmer engagement and offering crop advisory, product guidance, and loyalty benefits.
- The company improved its S&P Global Corporate Sustainability ranking to the 98th percentile, highlighting its commitment to sustainability.
- PI Industries Ltd (BOM:523642) maintains a debt-free balance sheet with net cash of INR35 billion, providing strong resilience and flexibility for strategic investments.
- The global Crop Protection market is experiencing a prolonged downcycle due to adverse weather conditions, soft commodity prices, and elevated interest rates, impacting PI Industries Ltd (BOM:523642)'s performance.
- Domestic agrochemical demand remains subdued due to high channel inventory and low commodity prices, affecting the company's revenue.
- The company's trade working capital has increased to 139 days, reflecting current market conditions and posing a challenge to liquidity management.
- PI Industries Ltd (BOM:523642) faces near-term momentum moderation in its Pharma platform due to global biotech funding uncertainties.
- The company is experiencing a compression in price realization across its portfolio, impacting overall profitability.
Ladies and gentlemen, good morning and welcome to the PI Industries Limited Q3 FY26 earnings conference call.
(Operator Instructions) Please note that this conference is being recorded.
I will now hand the conference over to Mr. Siddharth Rangnekar from CDR India for opening remarks. Thank you and over to you, Siddharth.
Good morning, everyone. Thank you for joining us on PI Industries' quarter-three FY26 earnings conference call.
Today, we are joined by senior members of the management team, including Mr. Mayank Singhal, Executive Vice Chairperson and Managing Director; Mr. Rajnish Sarna, Joint Managing Director; Mr. Sanjay Agarwal, Group Chief Financial Officer; Dr. Atul Gupta, CEO of CSM - AgChem; Mr. Jagresh Rana, Global CEO of PI AgSciences; and Dr. Ramesh Subramanian, Global CEO of PI Health Sciences.
We shall begin the call with key perspectives from Mr. Singhal. Following that, Mr. Agarwal will share his views on the company's financial performance.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
